title: [REMINDER Study: myocardial infarct without heart failure: does eplerenone have an advantage?].
authors.forename: Peter
authors.initials: P
authors.lastname: Overbeck
mesh_terms: D004311:Double-Blind Method; D061345:Early Medical Intervention; D000077545:Eplerenone; D005858:Germany; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D013148:Spironolactone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015996:Survival Rate
chemical_list: D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000077545:Eplerenone